Dubai’s free zones are drawing in businesses unfamiliar with the Middle East, thanks to a combination of an impressive infrastructure, sound business advice being on offer and low taxation.
Sectors
More- Aerospace
- Agribusiness
- Alternative/Renewable energy
- Automotive
- Automotive Components
- Automotive OEM
- Beverages
- Biotechnology
- BPO
- Building & Construction Materials
- Building and construction materials
- Business Machines & Equipment
- Business machines and equipment
- Business Services
- Ceramics & Glass
- Ceramics and glass
- Chemicals
- Coal, Oil & Natural Gas
- Communications
- Consumer Electronics
- Consumer Products
- Electronic Components
- Engines & Turbines
- Engines and turbines
- Financial Services
- Fintech
- Food & Tobacco
- Food and beverages
- Forestry
- Healthcare
- Hotels & Tourism
- Industrial Machinery, Equipment & Tools
- Industrial machinery, equipment and tools
- Information technology
- Infrastructure
- Leisure & Entertainment
- Leisure and entertainment
- Medical Devices
- Metals
- Minerals
- Non-Automotive Transport OEM
- Paper, Printing & Packaging
- Paper, printing and packaging
- Pharmaceuticals
- Plastics
- Real Estate
- Renewable energy
- Rubber
- Semiconductors
- Software & IT Services
- Space & Defence
- Space and defence
- Technology
- Textiles
- Tourism
- Traditional energy
- Transportation
- Warehousing & Storage
- Warehousing and storage
- Wood Products
From
Sectors
/ Pharmaceuticals
Ontario and Quebec up their biotech games
The leading two provinces for life sciences in Canada are not resting on their laurels when it comes to attracting investment, and both are now going all out to promote just how business-friendly their respective biotech clusters are.
From
Sectors
/ Pharmaceuticals
UK top European destination for pharmaceutical investments in 2012
Six pharmaceutical FDI projects have been recorded in the UK in the first quarter of 2012, making it the most popular destination in Europe for such investments.
From
Sectors
/ Pharmaceuticals
Johnson & Johnson takes outsourcing route to business growth
Julia Santos, head of global business optimisation for the Johnson & Johnson Group, explains to Barbara Njau why outsourcing is essential to the company’s business strategy.
From
Sectors
/ Pharmaceuticals
Time up for Medichem's Maltese haven?
Medichem has grown its Malta business out of the country’s patent-free status for drugs. But with Malta's entrance into the EU and changing legislation, the clock is ticking for the pharmaceuticals company
From
Sectors
/ Pharmaceuticals
Wallonia's reinvention
The Wallonia region in Belgium has remarketed itself to attract new partners and investor companies, and is carving a niche as a hub for pharmaceuticals and life sciences investment
From
Sectors
/ Pharmaceuticals
Big pharma gets bigger
The trend for amalgamation within the pharmaceutical sector is creating ever bigger and stronger companies, writes Lara Williams.
From
Sectors
/ Pharmaceuticals
An eye on expansion
The global of president Bausch & Lomb’s pharmaceutical division tells Lara Williams how the company’s global presence has helped it defy the economic slowdown, and that it now has Asia-Pacific, eastern Europe and Latin America in its sights.
« Previous 1 2 3
fDi Tools
fDi Intelligence has a portfolio of related products that enable you to get the targeted foreign investment information you need for your role:
For real-time crossborder greenfield investment data on all sectors and locations, click here
To benchmark locations for investment projects, click here
For bespoke reports on companies, locations or sectors, click here